Scientists are developing a vaccine to protect individuals from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the pandemic of coronavirus disease...
In a recent study posted on medRxiv* Preprint server, researchers Effectiveness Safety of Monoclonal Antibodies (mAbs) for the treatment of severe acute respiratory syndrome coronavirus 2...
Lincoln, Nebraska (WOWT)-Department of Health and Human Services, Nebraska Published a report on Health Alert Network on Tuesday Omicron variants say they have accounted for 52%...
Sotrovimab (GlaxoSmithKline), a monoclonal antibody, appears to reduce the risk of progression in mild to moderate cases of COVID-19 in patients at high risk of progression,...
Recent Comments